I'm referring to a legal document & asx approved announcement that says BioHealth will manufacture Canntab products.
The onus is on you Big Finn to prove why BioHealth in partnership with CGB & Medcann can't manufacture the tablet.
You have three Australian companies with a wealth of knowledge in their respective industries saying they can, written on a legal document.
I'm sure CGB will update the market in due time regarding any trial periods or associated steps in rolling out Canntab or any other mm product for that matter.
These rollouts may not happen over night but however you break the deal down it puts the CGB business plan years ahead.
I'm anticipating other products that will be manufactured at BioHealth will experience a much faster release in bulk to market.
The main priority is revenue all said & done, whether it comes in the near term from consumable hemp products & mm products at a later is not a problem.
Just enjoy this announcement Big Finn, if you need further clarification you can always try to contact CGB directly or stand by for further announcements.
No one is spoiling this announcement for me.
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
